000 03483nam a22003615i 4500
001 233223
003 ES-VaUE
005 20221220020446.0
007 cr nn 008mamaa
008 200817s2021 xxu| s |||| 0|eng d
020 _a9781071609125
024 7 _a10.1007/978-1-0716-0912-5
_2doi
040 _aES-MaUEC
_bspa
_cES-MaUEC
245 1 0 _aClinical Trials In Parkinson's Disease
_cedited by Santiago Perez-Lloret.
250 _a1st edition 2021
264 1 _aNew York, NY
_bSpringer International Publising
_c2021
300 _a1 recurso en línea (XV, 396 páginas)
_b10 ilustraciones, 5 ilustraciones a color
336 _atexto
_btxt
_2rdacontent
337 _aelectrónico
_bc
_2rdamedia
338 _arecurso electrónico
_bcr
_2rdacarrier
347 _aarchivo de texto
_bPDF
490 0 _aNeuromethods
_x1940-6045
_v160
505 0 _aToxin-Based Rodent Models of Parkinson's Disease -- Assessment of Non-Motor Symptoms in Rodent Models of Parkinson's Disease -- Genetic Models of Parkinson's Disease -- A Review of Randomized Phase III Pharmacological Clinical Trials for Motor Symptoms in Parkinson's Disease Patients and Quality of Evidence Recommendations -- Clinical Trials for Motor Complications in Parkinson's Disease -- Clinical Trials for Gait Disorders in Parkinson's Disease -- Clinical Trials for Disease Modifying Agents in Parkinson's Disease -- Value and Methods of Pharmacovigilance in the Monitoring of Drug Safety in Parkinson's Disease -- Clinical Trials for Cognitive Impairment and Dementia in Parkinson's Disease -- Clinical Trials for Depression, Anxiety, Fatigue, and Apathy in Parkinson's Disease -- Clinical Trials for Sleep Disorders and Daytime Somnolence in Parkinson's Disease -- Clinical Trials on Management of Pain in Parkinson's Disease -- Clinical Trials for Orthostatic Hypotension in Parkinson's Disease and Other Synucleinopathies -- Clinical Trials for Erectile Dysfunction in Parkinson's Disease -- Clinical Trials for Constipation in Parkinson's Disease.
520 _aThis volume looks at major clinical trials for motor and non-motor symptoms in Parkinson's Disease (PD) and covers important aspects, including trial design, sample selection, and outcome selection. Chapters in this book discuss topics such as toxin-based rodent or genetic models of PD; clinical trials for motor symptoms, L-DOPA related motor complications, and gait disorders; clinical trials for mood disorders, troubled sleep, autonomic dysfunction; and clinical trials for disease modifying therapies. In the Neuromethods series style, chapters include the kind of detail and key advice from the specialists needed to get successful results in your laboratory or research center. Cutting-edge and authoritative, Clinical Trials in Parkinson's Disease is a valuable resource for clinicians and researchers who want to enhance their interpretation of results from clinical trials and to design their own high-quality trials. .
700 1 _aPerez-Lloret, Santiago
_eeditor literario
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
776 0 8 _iPrinted edition:
_z9781071609118
776 0 8 _iPrinted edition:
_z9781071609132
776 0 8 _iPrinted edition:
_z9781071609149
856 4 0 _uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-1-0716-0912-5
_z(usuarios Universidad Europea de Valencia)
942 _2lcc
_cLE
988 _aSpringer_Protocols_2021
999 _c233223
_d233223